As of September 2026 Amylyx Pharmaceuticals has a market cap of A$5.27 Billion. This makes Amylyx Pharmaceuticals the world's 3770th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Sep 1st, 2026 the market cap of Amylyx Pharmaceuticals was reported to be: